Business Context and Reporting Period
This Form 8-K was filed by LabStyle Innovations Corp. (not Dariohealth Corp.) on April 12, 2013. The filing serves as a Regulation FD disclosure to make the Company's current Corporate Presentation available to the public.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document solely references an attached Corporate Presentation (Exhibit 99.1) which contains the Company's operational and financial details.
Material Changes
No material changes to financial performance or operations are reported within the text of this filing. The report is procedural, intended to distribute the Corporate Presentation via the SEC and the Company's website (www.mydario.com).
Guidance, Outlook, and Risks
The filing explicitly states that the information contained herein, including the attached presentation, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, no specific guidance, outlook, or risk factors are detailed in the body of this report.
Key Facts for Investor Verification
- Verify the correct registrant name is LabStyle Innovations Corp., not Dariohealth Corp.
- Review Exhibit 99.1 (Corporate Presentation) for actual financial data and business metrics.
- Note that the presentation is not legally "filed" under the Exchange Act and is not incorporated by reference into other filings unless specifically stated.
- Confirm the presentation is accessible on the Company's website at www.mydario.com.